IDEAS home Printed from https://ideas.repec.org/p/hal/journl/hal-05556453.html

Pharmaceutical life cycle management and access to medicine in times of COVID-19 pandemic
[Gestion du cycle de vie des produits pharmaceutiques et accès aux médicaments en période de pandémie de COVID-19]

Author

Listed:
  • Samira Guennif

    (Université Sorbonne Paris Nord, IRIS - Institut de Recherche Interdisciplinaire sur les enjeux Sociaux - sciences sociales, politique, santé - EHESS - École des hautes études en sciences sociales - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique - Université Sorbonne Paris Nord)

Abstract

When the COVID-19 pandemic broke out in March 2020, the urgent need to treat millions of patients worldwide led to a rush to drug "repurposing" (i.e. the recycling of existing drugs to treat new diseases) and induced strategic behavior by firms. Based on a literature survey and a review of online databases designed to collect unbiased secondary data, this article proposes a comparative case study of the divergent strategies followed by two firms holding patents (Abbvie and Gilead) for two repurposed drugs (respectively Kaletra and Remdesivir) in the midst of a pandemic. Establishing stylized facts and a chronology of events, this case study retraces the trajectory of two repurposed drugs for COVID-19 and explains why the firms adopted a more or less offensive life cycle management of their products in order to ensure exclusive marketing, to gain rents with the ultimate risk of limiting access to vital medicines. This study discusses finally the innovation system and its discontents in a new global pandemic.

Suggested Citation

  • Samira Guennif, 2024. "Pharmaceutical life cycle management and access to medicine in times of COVID-19 pandemic [Gestion du cycle de vie des produits pharmaceutiques et accès aux médicaments en période de pandémie de COVID-19]," Post-Print hal-05556453, HAL.
  • Handle: RePEc:hal:journl:hal-05556453
    DOI: 10.48611/isbn.978-2-406-17198-0.p.0119
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-05556453. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.